14-Deoxy-11,12-didehydroandrographolide (AND2), an analogue of
andrographolide, showed more potent cytotoxicity against human promonocytic
leukemia (THP-1) cells than adherent
cancer cell lines. In this study AND2 was isolated from the plant Andrographis paniculata and it was characterized. The antiproliferative effect of AND2 on both adherent (PC-3 and MDAMB) and non-adherent (THP-1 and Jurkat)
cancer cell lines was evaluated by MTT assay. The effect of intracellular
reduced glutathione (GSH) on AND2-induced cytotoxicity was studied by conducting cell viability assays on GSH-pretreated cells. The effect of AND2 on the redox status of THP-1 cells was determined by analyzing the endogenous reduced GSH content. Apoptosis induction was confirmed by
DNA laddering assay and Western blot analysis using anti-caspase-3
protein antibody. AND2 showed antiproliferative action on both THP-1 and Jurkat
cancer cell lines with low IC50 values. Cytotoxicity of AND2 was reversed by GSH pretreatment. AND2 treatment decreased the GSH content by 19.76 % (p < 0.001) in the THP-1
cancer cell line and reduced the cell clumping between the THP-1 cells. Expression of
procaspase-3 varied in THP-1 cells during the time course of AND2 treatment.
Procaspase-3 expression reached a maximum in treated cells at 32 h and was markedly reduced at 48 h but no
procaspase-3 cleavage was observed. The obtained results suggest that AND2 is more effective against
leukemia cells. AND2 induced a redox-mediated cell death in THP-1 cells. As AND2 temporarily increased the
procaspase-3 expression during treatment, this study encourages the preclinical testing of AND2 against promonocytic
leukemia cells in combination with small molecules that directly activate
procaspase-3 to
caspase-3.